Press Releases
Amarantus Completes Tender Exchange of Convertible Securities; CEO attending CNBC's Healthy Returns conference in New York City
Elto Pharma Receives Notice of Allowance in Australia for Patent Covering Eltoprazine in the Treatment of Parkinson's Levodopa-induced Dyskinesia
Elto Pharma to Present and Participate in Neuroscience Panel at Sachs BioCapital USA Forum
MANF Therapeutics Announces the Issuance of U.S. Patent #9,891,231
Amarantus Enters into Definitive Agreements for up to $1.5 Million in Funding
Amarantus Subsidiary MANF Therapeutics Announces Positive Independent Peer-Reviewed Pre-Clinical Data for MANF in Parkinson’s Disease
Amarantus Subsidiary Cutanogen Corporation Announces Issuance of US Patent 14/299,480 Covering ESS, Pigmented ESS and Gene Therapy-Modified ESS
Amarantus Provides Update on Capital Restructuring and Announces Participation in RESI JPM 2018